Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VIS410 + Oseltamivir in Hospitalized Influenza A
NCT03040141Phase 2Completed
- Sponsor
- Visterra
- Start
- Jan 2018
- Primary completion
- Nov 2018
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 20
01
Overview
A Phase 2 trial of VIS410 in Influenza A (IAV), sponsored by Visterra. Started Jan 2018; status: completed.
02
Drugs
VIS410
03
Conditions
Influenza A (IAV)
Beyond the preview
Go deeper on NCT03040141.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03040141.